Global Lyme Disease Diagnostic Service Market Growth (Status and Outlook) 2022-2028
The global market for Lyme Disease Diagnostic Service is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Lyme Disease Diagnostic Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Lyme Disease Diagnostic Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Lyme Disease Diagnostic Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Lyme Disease Diagnostic Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Lyme Disease Diagnostic Service players cover Quidel Corporation, Roche Holding AG, Fujirebio（H.U. Group Holdings）, ZEUS Scientific and IGeneX, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Lyme Disease Diagnostic Service market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Lyme Disease Diagnostic Service market, with both quantitative and qualitative data, to help readers understand how the Lyme Disease Diagnostic Service market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Lyme Disease Diagnostic Service market and forecasts the market size by Type (ELISA, Western Blotting and PCR), by Application (Individual, Hospitals and Testing Institutions and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
ELISA
Western Blotting
PCR
Others
Segmentation by application
Individual
Hospitals and Testing Institutions
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Quidel Corporation
Roche Holding AG
Fujirebio（H.U. Group Holdings）
ZEUS Scientific
IGeneX
Thermo Fisher Scientific
Everlywell
Oxford Immunotec Global PLC(PerkinElmer)
BioMerieux
Bio-Rad Laboratories
T2 Biosystems
Chapter Introduction
Chapter 1: Scope of Lyme Disease Diagnostic Service, Research Methodology, etc.
Chapter 2: Executive Summary, global Lyme Disease Diagnostic Service market size and CAGR, Lyme Disease Diagnostic Service market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Lyme Disease Diagnostic Service revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Lyme Disease Diagnostic Service revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Lyme Disease Diagnostic Service market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Quidel Corporation, Roche Holding AG, Fujirebio（H.U. Group Holdings）, ZEUS Scientific, IGeneX, Thermo Fisher Scientific, Everlywell, Oxford Immunotec Global PLC(PerkinElmer) and BioMerieux, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lyme Disease Diagnostic Service Market Size 2017-2028
2.1.2 Lyme Disease Diagnostic Service Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Lyme Disease Diagnostic Service Segment by Type
2.2.1 ELISA
2.2.2 Western Blotting
2.2.3 PCR
2.2.4 Others
2.3 Lyme Disease Diagnostic Service Market Size by Type
2.3.1 Lyme Disease Diagnostic Service Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Lyme Disease Diagnostic Service Market Size Market Share by Type (2017-2022)
2.4 Lyme Disease Diagnostic Service Segment by Application
2.4.1 Individual
2.4.2 Hospitals and Testing Institutions
2.4.3 Others
2.5 Lyme Disease Diagnostic Service Market Size by Application
2.5.1 Lyme Disease Diagnostic Service Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Lyme Disease Diagnostic Service Market Size Market Share by Application (2017-2022)
3 Lyme Disease Diagnostic Service Market Size by Player
3.1 Lyme Disease Diagnostic Service Market Size Market Share by Players
3.1.1 Global Lyme Disease Diagnostic Service Revenue by Players (2020-2022)
3.1.2 Global Lyme Disease Diagnostic Service Revenue Market Share by Players (2020-2022)
3.2 Global Lyme Disease Diagnostic Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Lyme Disease Diagnostic Service by Regions
4.1 Lyme Disease Diagnostic Service Market Size by Regions (2017-2022)
4.2 Americas Lyme Disease Diagnostic Service Market Size Growth (2017-2022)
4.3 APAC Lyme Disease Diagnostic Service Market Size Growth (2017-2022)
4.4 Europe Lyme Disease Diagnostic Service Market Size Growth (2017-2022)
4.5 Middle East & Africa Lyme Disease Diagnostic Service Market Size Growth (2017-2022)
5 Americas
5.1 Americas Lyme Disease Diagnostic Service Market Size by Country (2017-2022)
5.2 Americas Lyme Disease Diagnostic Service Market Size by Type (2017-2022)
5.3 Americas Lyme Disease Diagnostic Service Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lyme Disease Diagnostic Service Market Size by Region (2017-2022)
6.2 APAC Lyme Disease Diagnostic Service Market Size by Type (2017-2022)
6.3 APAC Lyme Disease Diagnostic Service Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Lyme Disease Diagnostic Service by Country (2017-2022)
7.2 Europe Lyme Disease Diagnostic Service Market Size by Type (2017-2022)
7.3 Europe Lyme Disease Diagnostic Service Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lyme Disease Diagnostic Service by Region (2017-2022)
8.2 Middle East & Africa Lyme Disease Diagnostic Service Market Size by Type (2017-2022)
8.3 Middle East & Africa Lyme Disease Diagnostic Service Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Lyme Disease Diagnostic Service Market Forecast
10.1 Global Lyme Disease Diagnostic Service Forecast by Regions (2023-2028)
10.1.1 Global Lyme Disease Diagnostic Service Forecast by Regions (2023-2028)
10.1.2 Americas Lyme Disease Diagnostic Service Forecast
10.1.3 APAC Lyme Disease Diagnostic Service Forecast
10.1.4 Europe Lyme Disease Diagnostic Service Forecast
10.1.5 Middle East & Africa Lyme Disease Diagnostic Service Forecast
10.2 Americas Lyme Disease Diagnostic Service Forecast by Country (2023-2028)
10.2.1 United States Lyme Disease Diagnostic Service Market Forecast
10.2.2 Canada Lyme Disease Diagnostic Service Market Forecast
10.2.3 Mexico Lyme Disease Diagnostic Service Market Forecast
10.2.4 Brazil Lyme Disease Diagnostic Service Market Forecast
10.3 APAC Lyme Disease Diagnostic Service Forecast by Region (2023-2028)
10.3.1 China Lyme Disease Diagnostic Service Market Forecast
10.3.2 Japan Lyme Disease Diagnostic Service Market Forecast
10.3.3 Korea Lyme Disease Diagnostic Service Market Forecast
10.3.4 Southeast Asia Lyme Disease Diagnostic Service Market Forecast
10.3.5 India Lyme Disease Diagnostic Service Market Forecast
10.3.6 Australia Lyme Disease Diagnostic Service Market Forecast
10.4 Europe Lyme Disease Diagnostic Service Forecast by Country (2023-2028)
10.4.1 Germany Lyme Disease Diagnostic Service Market Forecast
10.4.2 France Lyme Disease Diagnostic Service Market Forecast
10.4.3 UK Lyme Disease Diagnostic Service Market Forecast
10.4.4 Italy Lyme Disease Diagnostic Service Market Forecast
10.4.5 Russia Lyme Disease Diagnostic Service Market Forecast
10.5 Middle East & Africa Lyme Disease Diagnostic Service Forecast by Region (2023-2028)
10.5.1 Egypt Lyme Disease Diagnostic Service Market Forecast
10.5.2 South Africa Lyme Disease Diagnostic Service Market Forecast
10.5.3 Israel Lyme Disease Diagnostic Service Market Forecast
10.5.4 Turkey Lyme Disease Diagnostic Service Market Forecast
10.5.5 GCC Countries Lyme Disease Diagnostic Service Market Forecast
10.6 Global Lyme Disease Diagnostic Service Forecast by Type (2023-2028)
10.7 Global Lyme Disease Diagnostic Service Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Quidel Corporation
11.1.1 Quidel Corporation Company Information
11.1.2 Quidel Corporation Lyme Disease Diagnostic Service Product Offered
11.1.3 Quidel Corporation Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Quidel Corporation Main Business Overview
11.1.5 Quidel Corporation Latest Developments
11.2 Roche Holding AG
11.2.1 Roche Holding AG Company Information
11.2.2 Roche Holding AG Lyme Disease Diagnostic Service Product Offered
11.2.3 Roche Holding AG Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Roche Holding AG Main Business Overview
11.2.5 Roche Holding AG Latest Developments
11.3 Fujirebio（H.U. Group Holdings）
11.3.1 Fujirebio（H.U. Group Holdings） Company Information
11.3.2 Fujirebio（H.U. Group Holdings） Lyme Disease Diagnostic Service Product Offered
11.3.3 Fujirebio（H.U. Group Holdings） Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Fujirebio（H.U. Group Holdings） Main Business Overview
11.3.5 Fujirebio（H.U. Group Holdings） Latest Developments
11.4 ZEUS Scientific
11.4.1 ZEUS Scientific Company Information
11.4.2 ZEUS Scientific Lyme Disease Diagnostic Service Product Offered
11.4.3 ZEUS Scientific Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 ZEUS Scientific Main Business Overview
11.4.5 ZEUS Scientific Latest Developments
11.5 IGeneX
11.5.1 IGeneX Company Information
11.5.2 IGeneX Lyme Disease Diagnostic Service Product Offered
11.5.3 IGeneX Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 IGeneX Main Business Overview
11.5.5 IGeneX Latest Developments
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Information
11.6.2 Thermo Fisher Scientific Lyme Disease Diagnostic Service Product Offered
11.6.3 Thermo Fisher Scientific Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Thermo Fisher Scientific Main Business Overview
11.6.5 Thermo Fisher Scientific Latest Developments
11.7 Everlywell
11.7.1 Everlywell Company Information
11.7.2 Everlywell Lyme Disease Diagnostic Service Product Offered
11.7.3 Everlywell Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Everlywell Main Business Overview
11.7.5 Everlywell Latest Developments
11.8 Oxford Immunotec Global PLC(PerkinElmer)
11.8.1 Oxford Immunotec Global PLC(PerkinElmer) Company Information
11.8.2 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Diagnostic Service Product Offered
11.8.3 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Oxford Immunotec Global PLC(PerkinElmer) Main Business Overview
11.8.5 Oxford Immunotec Global PLC(PerkinElmer) Latest Developments
11.9 BioMerieux
11.9.1 BioMerieux Company Information
11.9.2 BioMerieux Lyme Disease Diagnostic Service Product Offered
11.9.3 BioMerieux Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 BioMerieux Main Business Overview
11.9.5 BioMerieux Latest Developments
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Information
11.10.2 Bio-Rad Laboratories Lyme Disease Diagnostic Service Product Offered
11.10.3 Bio-Rad Laboratories Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Bio-Rad Laboratories Main Business Overview
11.10.5 Bio-Rad Laboratories Latest Developments
11.11 T2 Biosystems
11.11.1 T2 Biosystems Company Information
11.11.2 T2 Biosystems Lyme Disease Diagnostic Service Product Offered
11.11.3 T2 Biosystems Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 T2 Biosystems Main Business Overview
11.11.5 T2 Biosystems Latest Developments
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Lyme Disease Diagnostic Service Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of ELISA
Table 3. Major Players of Western Blotting
Table 4. Major Players of PCR
Table 5. Major Players of Others
Table 6. Lyme Disease Diagnostic Service Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Lyme Disease Diagnostic Service Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Lyme Disease Diagnostic Service Market Size Market Share by Type (2017-2022)
Table 9. Lyme Disease Diagnostic Service Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Lyme Disease Diagnostic Service Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Lyme Disease Diagnostic Service Market Size Market Share by Application (2017-2022)
Table 12. Global Lyme Disease Diagnostic Service Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Lyme Disease Diagnostic Service Revenue Market Share by Player (2020-2022)
Table 14. Lyme Disease Diagnostic Service Key Players Head office and Products Offered
Table 15. Lyme Disease Diagnostic Service Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Lyme Disease Diagnostic Service Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Lyme Disease Diagnostic Service Market Size Market Share by Regions (2017-2022)
Table 20. Americas Lyme Disease Diagnostic Service Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Lyme Disease Diagnostic Service Market Size Market Share by Country (2017-2022)
Table 22. Americas Lyme Disease Diagnostic Service Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Lyme Disease Diagnostic Service Market Size Market Share by Type (2017-2022)
Table 24. Americas Lyme Disease Diagnostic Service Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Lyme Disease Diagnostic Service Market Size Market Share by Application (2017-2022)
Table 26. APAC Lyme Disease Diagnostic Service Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Lyme Disease Diagnostic Service Market Size Market Share by Region (2017-2022)
Table 28. APAC Lyme Disease Diagnostic Service Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Lyme Disease Diagnostic Service Market Size Market Share by Type (2017-2022)
Table 30. APAC Lyme Disease Diagnostic Service Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Lyme Disease Diagnostic Service Market Size Market Share by Application (2017-2022)
Table 32. Europe Lyme Disease Diagnostic Service Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Lyme Disease Diagnostic Service Market Size Market Share by Country (2017-2022)
Table 34. Europe Lyme Disease Diagnostic Service Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Lyme Disease Diagnostic Service Market Size Market Share by Type (2017-2022)
Table 36. Europe Lyme Disease Diagnostic Service Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Lyme Disease Diagnostic Service Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Lyme Disease Diagnostic Service Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Lyme Disease Diagnostic Service Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Lyme Disease Diagnostic Service Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Lyme Disease Diagnostic Service Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Lyme Disease Diagnostic Service Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Lyme Disease Diagnostic Service Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Lyme Disease Diagnostic Service
Table 45. Key Market Challenges & Risks of Lyme Disease Diagnostic Service
Table 46. Key Industry Trends of Lyme Disease Diagnostic Service
Table 47. Global Lyme Disease Diagnostic Service Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Lyme Disease Diagnostic Service Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Lyme Disease Diagnostic Service Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Lyme Disease Diagnostic Service Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Lyme Disease Diagnostic Service Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Lyme Disease Diagnostic Service Market Size Market Share Forecast by Application (2023-2028)
Table 53. Quidel Corporation Details, Company Type, Lyme Disease Diagnostic Service Area Served and Its Competitors
Table 54. Quidel Corporation Lyme Disease Diagnostic Service Product Offered
Table 55. Quidel Corporation Lyme Disease Diagnostic Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Quidel Corporation Main Business
Table 57. Quidel Corporation Latest Developments
Table 58. Roche Holding AG Details, Company Type, Lyme Disease Diagnostic Service Area Served and Its Competitors
Table 59. Roche Holding AG Lyme Disease Diagnostic Service Product Offered
Table 60. Roche Holding AG Main Business
Table 61. Roche Holding AG Lyme Disease Diagnostic Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Roche Holding AG Latest Developments
Table 63. Fujirebio（H.U. Group Holdings） Details, Company Type, Lyme Disease Diagnostic Service Area Served and Its Competitors
Table 64. Fujirebio（H.U. Group Holdings） Lyme Disease Diagnostic Service Product Offered
Table 65. Fujirebio（H.U. Group Holdings） Main Business
Table 66. Fujirebio（H.U. Group Holdings） Lyme Disease Diagnostic Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Fujirebio（H.U. Group Holdings） Latest Developments
Table 68. ZEUS Scientific Details, Company Type, Lyme Disease Diagnostic Service Area Served and Its Competitors
Table 69. ZEUS Scientific Lyme Disease Diagnostic Service Product Offered
Table 70. ZEUS Scientific Main Business
Table 71. ZEUS Scientific Lyme Disease Diagnostic Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. ZEUS Scientific Latest Developments
Table 73. IGeneX Details, Company Type, Lyme Disease Diagnostic Service Area Served and Its Competitors
Table 74. IGeneX Lyme Disease Diagnostic Service Product Offered
Table 75. IGeneX Main Business
Table 76. IGeneX Lyme Disease Diagnostic Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. IGeneX Latest Developments
Table 78. Thermo Fisher Scientific Details, Company Type, Lyme Disease Diagnostic Service Area Served and Its Competitors
Table 79. Thermo Fisher Scientific Lyme Disease Diagnostic Service Product Offered
Table 80. Thermo Fisher Scientific Main Business
Table 81. Thermo Fisher Scientific Lyme Disease Diagnostic Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Thermo Fisher Scientific Latest Developments
Table 83. Everlywell Details, Company Type, Lyme Disease Diagnostic Service Area Served and Its Competitors
Table 84. Everlywell Lyme Disease Diagnostic Service Product Offered
Table 85. Everlywell Main Business
Table 86. Everlywell Lyme Disease Diagnostic Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Everlywell Latest Developments
Table 88. Oxford Immunotec Global PLC(PerkinElmer) Details, Company Type, Lyme Disease Diagnostic Service Area Served and Its Competitors
Table 89. Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Diagnostic Service Product Offered
Table 90. Oxford Immunotec Global PLC(PerkinElmer) Main Business
Table 91. Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Diagnostic Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. Oxford Immunotec Global PLC(PerkinElmer) Latest Developments
Table 93. BioMerieux Details, Company Type, Lyme Disease Diagnostic Service Area Served and Its Competitors
Table 94. BioMerieux Lyme Disease Diagnostic Service Product Offered
Table 95. BioMerieux Main Business
Table 96. BioMerieux Lyme Disease Diagnostic Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. BioMerieux Latest Developments
Table 98. Bio-Rad Laboratories Details, Company Type, Lyme Disease Diagnostic Service Area Served and Its Competitors
Table 99. Bio-Rad Laboratories Lyme Disease Diagnostic Service Product Offered
Table 100. Bio-Rad Laboratories Main Business
Table 101. Bio-Rad Laboratories Lyme Disease Diagnostic Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 102. Bio-Rad Laboratories Latest Developments
Table 103. T2 Biosystems Details, Company Type, Lyme Disease Diagnostic Service Area Served and Its Competitors
Table 104. T2 Biosystems Lyme Disease Diagnostic Service Product Offered
Table 105. T2 Biosystems Lyme Disease Diagnostic Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 106. T2 Biosystems Main Business
Table 107. T2 Biosystems Latest Developments
List of Figures
List of Figures
Figure 1. Lyme Disease Diagnostic Service Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Lyme Disease Diagnostic Service Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Lyme Disease Diagnostic Service Market Size Market Share by Type in 2021
Figure 7. Lyme Disease Diagnostic Service in Individual
Figure 8. Global Lyme Disease Diagnostic Service Market: Individual (2017-2022) & ($ Millions)
Figure 9. Lyme Disease Diagnostic Service in Hospitals and Testing Institutions
Figure 10. Global Lyme Disease Diagnostic Service Market: Hospitals and Testing Institutions (2017-2022) & ($ Millions)
Figure 11. Lyme Disease Diagnostic Service in Others
Figure 12. Global Lyme Disease Diagnostic Service Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Lyme Disease Diagnostic Service Market Size Market Share by Application in 2021
Figure 14. Global Lyme Disease Diagnostic Service Revenue Market Share by Player in 2021
Figure 15. Global Lyme Disease Diagnostic Service Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Lyme Disease Diagnostic Service Market Size 2017-2022 ($ Millions)
Figure 17. APAC Lyme Disease Diagnostic Service Market Size 2017-2022 ($ Millions)
Figure 18. Europe Lyme Disease Diagnostic Service Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Lyme Disease Diagnostic Service Market Size 2017-2022 ($ Millions)
Figure 20. Americas Lyme Disease Diagnostic Service Value Market Share by Country in 2021
Figure 21. Americas Lyme Disease Diagnostic Service Consumption Market Share by Type in 2021
Figure 22. Americas Lyme Disease Diagnostic Service Market Size Market Share by Application in 2021
Figure 23. United States Lyme Disease Diagnostic Service Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Lyme Disease Diagnostic Service Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Lyme Disease Diagnostic Service Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Lyme Disease Diagnostic Service Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Lyme Disease Diagnostic Service Market Size Market Share by Region in 2021
Figure 28. APAC Lyme Disease Diagnostic Service Market Size Market Share by Application in 2021
Figure 29. China Lyme Disease Diagnostic Service Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Lyme Disease Diagnostic Service Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Lyme Disease Diagnostic Service Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Lyme Disease Diagnostic Service Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Lyme Disease Diagnostic Service Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Lyme Disease Diagnostic Service Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Lyme Disease Diagnostic Service Market Size Market Share by Country in 2021
Figure 36. Europe Lyme Disease Diagnostic Service Market Size Market Share by Type in 2021
Figure 37. Europe Lyme Disease Diagnostic Service Market Size Market Share by Application in 2021
Figure 38. Germany Lyme Disease Diagnostic Service Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Lyme Disease Diagnostic Service Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Lyme Disease Diagnostic Service Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Lyme Disease Diagnostic Service Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Lyme Disease Diagnostic Service Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Lyme Disease Diagnostic Service Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Lyme Disease Diagnostic Service Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Lyme Disease Diagnostic Service Market Size Market Share by Application in 2021
Figure 46. Egypt Lyme Disease Diagnostic Service Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Lyme Disease Diagnostic Service Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Lyme Disease Diagnostic Service Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Lyme Disease Diagnostic Service Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Lyme Disease Diagnostic Service Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Lyme Disease Diagnostic Service Market Size 2023-2028 ($ Millions)
Figure 52. APAC Lyme Disease Diagnostic Service Market Size 2023-2028 ($ Millions)
Figure 53. Europe Lyme Disease Diagnostic Service Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Lyme Disease Diagnostic Service Market Size 2023-2028 ($ Millions)
Figure 55. United States Lyme Disease Diagnostic Service Market Size 2023-2028 ($ Millions)
Figure 56. Canada Lyme Disease Diagnostic Service Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Lyme Disease Diagnostic Service Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Lyme Disease Diagnostic Service Market Size 2023-2028 ($ Millions)
Figure 59. China Lyme Disease Diagnostic Service Market Size 2023-2028 ($ Millions)
Figure 60. Japan Lyme Disease Diagnostic Service Market Size 2023-2028 ($ Millions)
Figure 61. Korea Lyme Disease Diagnostic Service Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Lyme Disease Diagnostic Service Market Size 2023-2028 ($ Millions)
Figure 63. India Lyme Disease Diagnostic Service Market Size 2023-2028 ($ Millions)
Figure 64. Australia Lyme Disease Diagnostic Service Market Size 2023-2028 ($ Millions)
Figure 65. Germany Lyme Disease Diagnostic Service Market Size 2023-2028 ($ Millions)
Figure 66. France Lyme Disease Diagnostic Service Market Size 2023-2028 ($ Millions)
Figure 67. UK Lyme Disease Diagnostic Service Market Size 2023-2028 ($ Millions)
Figure 68. Italy Lyme Disease Diagnostic Service Market Size 2023-2028 ($ Millions)
Figure 69. Russia Lyme Disease Diagnostic Service Market Size 2023-2028 ($ Millions)
Figure 70. Spain Lyme Disease Diagnostic Service Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Lyme Disease Diagnostic Service Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Lyme Disease Diagnostic Service Market Size 2023-2028 ($ Millions)
Figure 73. Israel Lyme Disease Diagnostic Service Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Lyme Disease Diagnostic Service Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Lyme Disease Diagnostic Service Market Size 2023-2028 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets